About 47,200 results
Open links in new tab
  1. Olaris, Inc | Biomarkers of Response (BoRs) | Framingham, Massachusetts

    Using metabolomics and machine learning, Olaris ® develops in vitro diagnostics that empower patients, providers, and biopharma to pursue the most effective treatments.

  2. Volaris - Ultra low cost airline with the cheapest flight deals-Volaris

    Volaris - Ultra low cost airline with the cheapest flight deals-Volaris.

  3. Olaris, Inc - LinkedIn

    Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize treatments and...

  4. Olaris Receives Strategic Investment from Labcorp to Advance

    Apr 8, 2025 · Olaris, Inc., is working to fundamentally change how diseases are treated and diagnosed. By leveraging our myOLARIS™ toolbox which combines metabolomics, machine learning and …

  5. Olaris: Strategic Investment Raised From Labcorp

    Apr 11, 2025 · Olaris, a precision medicine company leveraging metabolomics and machine learning to discover and develop its myOLARIS diagnostics products, announced an investment from Labcorp, a …

  6. Olaris - Products, Competitors, Financials, Employees, Headquarters ...

    Olaris is a precision medicine company that focuses on metabolomics and machine learning in healthcare. The company works on in vitro diagnostics that use biomarkers for therapeutic selection …

  7. Olaris - Crunchbase Company Profile & Funding

    Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning

  8. Olaris - VentureRadar

    Apr 11, 2025 · "Olaris is a precision medicine company that utilizes metabolomics and machine learning to discover and develop diagnostic products. Their myOLARIS™ toolbox combines metabolomics, …

  9. Olaris - 2025 Company Profile, Funding & Competitors - Tracxn

    May 30, 2025 · Olaris is a series B company based in Waltham (United States), founded in 2014 by Liz Oday. It operates as a Developer of in-vitro diagnostics for oncology, solid-organ transplant, and …

  10. WHO WE ARE - Olaris, Inc

    Olaris is revolutionizing how diseases are diagnosed and treated by combining metabolomics and machine learning to develop precision diagnostics for the entire patient journey.